Jun 11, 2018 7:00am EDT Can-Fite Reports on New Pre-Clinical Developments with Its NASH Drug Namodenoson
Jun 01, 2018 7:00am EDT Can-Fite Reports First Quarter 2018 Financial Results and Provides Clinical Update
Apr 25, 2018 7:00am EDT Can-Fite's Piclidenoson Mechanism of Action in Psoriasis Published in 'Journal of Immunology Research'
Apr 09, 2018 7:00am EDT Can-Fite to Present the Anti-Inflammatory and Anti-Fibrogenic Effects of Namodenoson in NAFLD/NASH Pre-clinical Studies at the 2018 International Liver Congress of the European Association for the Study of the Liver (EASL)
Mar 14, 2018 7:00am EDT Can-Fite to Present at the NASH 2nd Annual H.C. Wainwright Investor Conference
Mar 06, 2018 7:00am EST Can-Fite to Participate in Panel Discussions on Latest Drug Developments in NASH at the 30th Annual ROTH Conference
